Wet Age-Related Macular Degeneration/Diabetic Macular Edema 
The MD Magazine Wet Age-Related Macular Degeneration/Diabetic Macular Edema condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Wet AMD: Aflibercept Best at Reducing Severe Increases in Pigment Epithelial Detachment Height
Researchers compared aflibercept, bevacizumab, and ranibizumab injections.
Of the 3 regimens, monthly aflibercept produced the greatest gain in mean BCVA.
Uveitis patients age ≥55 years are less likely to have large drusen than others.
Using red-channel separation gives a better picture in diagnosis of DME.
Screen for morphological risk factors for an RPE tear before each injection.
In most eyes, the mask reduced or resolved cysts in the OCT subfield.
Annual rate of ocular inflammatory flares fell from 200 to 49 per 100 patients.
Researchers find gap in antioxidant enzymes between AMD patients and controls.
Whether injected monthly or according to a TREX regimen, ranibizumab did not have a statistically significant effect on the development of new macular atrophy in eyes with neovascular AMD.

Most Popular


$vacMongoViewPlus$ $vAR$